{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:46:40Z","timestamp":1786985200426,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.bioorg.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T15:12:28Z","timestamp":1455981148000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Pentoxifylline affects idarubicin binding to DNA"],"prefix":"10.1016","volume":"65","author":[{"given":"Grzegorz","family":"Go\u0142u\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Borowik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lipi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Romanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Derewo\u0144ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Woziwodzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5671-1915","authenticated-orcid":false,"given":"Jacek","family":"Piosik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2016.02.005_b0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K","article-title":"Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia","volume":"20","author":"Tan","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2016.02.005_b0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0015","first-page":"5995","article-title":"Properties of antitumor anthracyclines and new developments in their application: cain memorial award lecture","volume":"45","author":"Arcamone","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2016.02.005_b0020","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.1093\/nar\/11.21.7555","article-title":"Increased accessibility of bases in DNA upon binding of acridine orange","volume":"11","author":"Kapuscinski","year":"1983","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2016.02.005_b0025","article-title":"Pentoxifylline as a modulator of anticancer drug doxorubicin. Part I: reduction of doxorubicin DNA binding","author":"Golunski","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2016.02.005_b0030","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/jps.2600730615","article-title":"Self-association of doxorubicin and related compounds in aqueous solution","volume":"73","author":"Menozzi","year":"1984","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2016.02.005_b0035","doi-asserted-by":"crossref","first-page":"923","DOI":"10.18388\/abp.2005_3408","article-title":"Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone","volume":"52","author":"Piosik","year":"2005","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0040","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0006-2952(01)00903-0","article-title":"The modulation by xanthines of the DNA-damaging effect of polycyclic aromatic agents. Part II. The stacking complexes of caffeine with doxorubicin and mitoxantrone","volume":"63","author":"Piosik","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0045","first-page":"3682","article-title":"Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198","volume":"51","author":"Traganos","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2016.02.005_b0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cplett.2006.10.008","article-title":"NMR investigation of the effect of caffeine on the hetero-association of an anticancer drug with a vitamin","volume":"432","author":"Evstigneev","year":"2006","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.bioorg.2016.02.005_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00249-006-0071-9","article-title":"Complexation of anthracycline drugs with DNA in the presence of caffeine","volume":"36","author":"Evstigneev","year":"2006","journal-title":"Eur. Biophys. J. Biophys. Lett."},{"key":"10.1016\/j.bioorg.2016.02.005_b0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jphotobiol.2014.05.015","article-title":"In vitro DNA binding studies of anticancer drug idarubicin using spectroscopic techniques","volume":"138","author":"Ozluer","year":"2014","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.bioorg.2016.02.005_b0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijbiomac.2013.05.027","article-title":"Structural investigation of idarubicin\u2013DNA interaction: spectroscopic and molecular docking study","volume":"60","author":"Charak","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0080","first-page":"CD005262","article-title":"Pentoxifylline for intermittent claudication","volume":"9","author":"Salhiyyah","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bioorg.2016.02.005_b0085","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0190-9622(94)70069-9","article-title":"Pentoxifylline","volume":"30","author":"Samlaska","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0027-5107(03)00136-2","article-title":"Alleviation of mutagenic effects of polycyclic aromatic agents (quinacrine mustard, ICR-191 and ICR-170) by caffeine and pentoxifylline","volume":"530","author":"Piosik","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bioorg.2016.02.005_b0095","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1016\/j.bmc.2013.03.043","article-title":"Modulation of acridine mutagen ICR191 intercalation to DNA by methylxanthines\u2013analysis with mathematical models","volume":"21","author":"Golunski","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.02.005_b0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bioorg.2010.11.001","article-title":"Caffeine, pentoxifylline and theophylline form stacking complexes with IQ-type heterocyclic aromatic amines","volume":"39","author":"Woziwodzka","year":"2011","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2016.02.005_b0105","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1021\/tx4002513","article-title":"Caffeine and other methylxanthines as interceptors of food-borne aromatic mutagens: inhibition of trp-p-1 and trp-p-2 mutagenic activity","volume":"26","author":"Woziwodzka","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/cbir.2001.0810","article-title":"Caffeine and other xanthines as cytochemical blockers and removers of heterocyclic DNA intercalators from chromatin","volume":"26","author":"Lyles","year":"2002","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bioorg.2016.02.005_b0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","article-title":"Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy","volume":"34","author":"Ward","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2016.02.005_b0120","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejphar.2013.07.004","article-title":"Curbing the focal adhesion kinase and its associated signaling events by pentoxifylline in MDA-MB-231 human breast cancer cells","volume":"714","author":"Goel","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11010-011-0929-8","article-title":"Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells","volume":"358","author":"Goel","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2016.02.005_b0130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0360-3016(92)90846-A","article-title":"Increases in tumor response by pentoxifylline alone or in combination with nicotinamide","volume":"22","author":"Lee","year":"1992","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bioorg.2016.02.005_b0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2307\/3578277","article-title":"Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline","volume":"130","author":"Song","year":"1992","journal-title":"Radiat. Res."},{"key":"10.1016\/j.bioorg.2016.02.005_b0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0301-4622(99)00152-0","article-title":"Thermodynamical model of mixed aggregation of ligands with caffeine in aqueous solution. Part II","volume":"84","author":"Zdunek","year":"2000","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bioorg.2016.02.005_b0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2013\/740821","article-title":"Heterocyclic aromatic amines heterocomplexation with biologically active aromatic compounds and its possible role in chemoprevention","volume":"2013","author":"Woziwodzka","year":"2013","journal-title":"ISRN Biophys."},{"key":"10.1016\/j.bioorg.2016.02.005_b0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10867-008-9124-x","article-title":"Complexation of biologically active aromatic compounds with DNA in the presence of theophylline","volume":"35","author":"Hernandez Santiago","year":"2009","journal-title":"J. Biol. Phys."},{"key":"10.1016\/j.bioorg.2016.02.005_b0145","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1016\/j.bmc.2007.05.025","article-title":"Impaired mutagenic activities of MPDP(+) (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP(+) (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines","volume":"15","author":"Ulanowska","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2016.02.005_b0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00008469-200104000-00004","article-title":"Colonic cell proliferation, apoptosis and aberrant crypt foci development in rats given 2-amino-3-methylimidazo [4,5-f] quinoline and treated post-initiation with chlorophyllin","volume":"10","author":"Dashwood","year":"2001","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.bioorg.2016.02.005_b0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/em.2850220309","article-title":"Antimutagenic potency of chlorophyllin in the Salmonella assay and its correlation with binding constants of mutagen-inhibitor complexes","volume":"22","author":"Dashwood","year":"1993","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.bioorg.2016.02.005_b0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biopha.2013.11.003","article-title":"Delineating the anti-metastatic potential of pentoxifylline in combination with liposomal doxorubicin against breast cancer cells","volume":"68","author":"Goel","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2016.02.005_b0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/cbr.1994.9.143","article-title":"In vitro effects of pentoxifylline and doxorubicin on cell survival and DNA damage in sensitive and MDR-P388 leukemia cells","volume":"9","author":"Viladkar","year":"1994","journal-title":"Cancer Biother."},{"key":"10.1016\/j.bioorg.2016.02.005_b0170","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0022-2836(74)90031-X","article-title":"Theoretical aspects of DNA\u2013protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice","volume":"86","author":"McGhee","year":"1974","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0175","first-page":"46","article-title":"Thermodynamical model of mixed aggregation of intercalators with caffeine in aqueous solution","volume":"35","author":"Kapuscinski","year":"1993","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bioorg.2016.02.005_b0180","first-page":"59","article-title":"De-intercalation of ethidium bromide and propidium iodine from DNA in the presence of caffeine","volume":"5","author":"Piosik","year":"2010","journal-title":"Cent. Eur. J. Biol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.molstruc.2008.01.051","article-title":"Structural and thermodynamic analysis of the hetero-association of theophylline with aromatic drug molecules","volume":"889","author":"Andrejuk","year":"2008","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2016.02.005_b0190","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1080\/00268970009483399","article-title":"1H NMR investigation of the hetero-association of aromatic molecules in aqueous solution: factors involved in the stabilization of complexes of daunomycin and acridine drugs","volume":"98","author":"Davies","year":"2000","journal-title":"Mol. Phys."},{"key":"10.1016\/j.bioorg.2016.02.005_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2015.10.035","article-title":"Modulation of vincristine and doxorubicin binding and release from silk films","author":"Coburn","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioorg.2016.02.005_b0200","doi-asserted-by":"crossref","first-page":"22960","DOI":"10.3390\/ijms151222960","article-title":"Modulation of induced cytotoxicity of doxorubicin by using apoferritin and liposomal cages","volume":"15","author":"Gumulec","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2016.02.005_b0205","doi-asserted-by":"crossref","first-page":"23164","DOI":"10.1039\/C4CP03367A","article-title":"Characterization of C60 fullerene complexation with antibiotic doxorubicin","volume":"16","author":"Prylutskyy","year":"2014","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bioorg.2016.02.005_b0210","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/cphc.201200938","article-title":"Complexation of C60 fullerene with aromatic drugs","volume":"14","author":"Evstigneev","year":"2013","journal-title":"ChemPhysChem"},{"key":"10.1016\/j.bioorg.2016.02.005_b0215","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/elps.201300393","article-title":"Fullerene as a transporter for doxorubicin investigated by analytical methods and in vivo imaging","volume":"35","author":"Blazkova","year":"2014","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bioorg.2016.02.005_b0220","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00249-014-0960-2","article-title":"Interceptor effect of C60 fullerene on the in vitro action of aromatic drug molecules","volume":"43","author":"Skamrova","year":"2014","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.bioorg.2016.02.005_b0225","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/am100037y","article-title":"Fullerene-conjugated doxorubicin in cells","volume":"2","author":"Liu","year":"2010","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioorg.2016.02.005_b0230","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1269\/jrr.46.373","article-title":"Increase in tumor oxygenation and potentiation of radiation effects using pentoxifylline, vinpocetine and ticlopidine hydrochloride","volume":"46","author":"Amano","year":"2005","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.bioorg.2016.02.005_b0235","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.ejca.2009.05.015","article-title":"Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5)","volume":"45","author":"Magnusson","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bioorg.2016.02.005_b0240","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.biopha.2012.03.006","article-title":"Preclinical evaluation of the antimetastatic efficacy of Pentoxifylline on A375 human melanoma cell line","volume":"66","author":"Kamran","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2016.02.005_b0245","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/0006-2952(85)90275-8","article-title":"Interactions of antitumor agents Ametantrone and Mitoxantrone (Novatrone) with double-stranded DNA","volume":"34","author":"Kapuscinski","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(88)90009-X","article-title":"The effect of pentoxifylline on endothelial permeability of rabbit carotid artery wall","volume":"150","author":"Strohschneider","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0255","first-page":"1066","article-title":"Permeability of the erythrocyte membrane to pentoxifylline and propentofylline. Research on their effects on some structural and functional properties of the membrane","volume":"36","author":"Chetrite","year":"1988","journal-title":"Pathol. Biol. (Paris)"},{"key":"10.1016\/j.bioorg.2016.02.005_b0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0162-3109(92)90076-O","article-title":"Methylxanthine-induced inhibition of the antigen- and superantigen-specific activation of T and B lymphocytes","volume":"24","author":"Rosenthal","year":"1992","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bioorg.2016.02.005_b0265","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/cpt197721170","article-title":"Plasma adriamycin and daunorubicin levels by fluorescence and radioimmunoassay","volume":"21","author":"Bachur","year":"1977","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2016.02.005_b0270","first-page":"1416","article-title":"Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function","volume":"37","author":"Benjamin","year":"1977","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2016.02.005_b0275","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02982064","article-title":"A pharmacokinetic study of idarubicin in Japanese patients with malignant lymphoma: relationship with leukocytopenia and neutropenia","volume":"74","author":"Fukushima","year":"2001","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bioorg.2016.02.005_b0280","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00210-002-0683-2","article-title":"Caffeine enhances myocardial uptake of idarubicin but reverses its negative inotropic effect","volume":"367","author":"Kang","year":"2003","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520681630013X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520681630013X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T18:05:01Z","timestamp":1600193101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520681630013X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":56,"alternative-id":["S004520681630013X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2016.02.005","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentoxifylline affects idarubicin binding to DNA","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2016.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}